Archives des Metabolic Conditions

The inflammatory potential of diet is tied to Crohn’s disease risk but not to ulcerative colitis, suggests a new observational study

2 Nov 2020

by Rene van den Wijngaard

Despite the fact that current guidelines for managing inflammatory bowel diseases do not devote attention to diet as a central element of treatment, there is an increasing amount of evidence that supports the role of diet in patients with IBD. A new nationwide cohort study shows the association between the level of inflammatory potential in diet and risk of Crohn’s disease.

New research shows the keto diet, used to treat neurological and metabolic diseases, suppresses bifidobacteria and Th17 cells

15 Jun 2020

by Andreu Prados

Could the keto diet’s therapeutic benefits be linked to changes in the gut microbiota? New work in mice and 17 men who are overweight or obese reveals ketone bodies exert suppression of bifidobacteria and intestinal pro-inflammatory Th17 cells.

Could the gut microbiota mediate the clinical benefits of statins?

2 Jun 2020

by GMFH Editing Team

Gut microbiota alterations in obesity remain the subject of debate. Writing in Nature, Vieira-Silva and colleagues found that the undesirable Bacteroides 2 enterotype was more frequent in people with a higher body mass index, but not if they were taking statins.

Will gut microbiota provide the solution to all of our health problems?

23 Apr 2020

by Patrice D. Cani

Gut microbiota, with its close links to metabolism and the immune system, could potentially be a factor that lies at the core of good health. This means it can be positioned at the heart of the processes that influence the risk of contracting different diseases.

Why the gut microbiome is behind the health effects of the Mediterranean diet

14 Apr 2020

by GMFH Editing Team

The Mediterranean dietary pattern has been largely associated with improved health outcomes. Two new randomized controlled trials reveal the contribution of gut microbiome composition and functions to explaining the potential beneficial effects of the Mediterranean diet.

Baseline gut microbiota may determine inulin effects on weight loss

16 Mar 2020

by GMFH Editing Team

Large inter-individual variability exists regarding how our gut microbiota responds to dietary intervention. New findings in mice and people with obesity show that ‘responders’ to inulin may be identifiable from their gut microbiota before they receive the intervention.

Gut microbiota composition tied to type 2 diabetes remission following bariatric surgery in obese diabetic women

9 Mar 2020

by Andreu Prados

Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.

A new review explores how the gastrointestinal sensing of meal-related stimuli occur in health and disease

10 Feb 2020

by GMFH Editing Team

A large proportion of the general population struggle with digestive symptoms that cannot be detected by conventional diagnostic methods. Understanding how the gastrointestinal tract responds to meal-related stimuli may help both in healthy conditions and in eating-related disorders.

2019 at a glance: Breakthroughs in the emerging role of gut microbiome in health and disease

13 Jan 2020

by GMFH Editing Team

Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.

New GMFH “best of” document presents current progress and health applications of synbiotics

28 Nov 2019

by GMFH Editing Team

Gibson and Roberfroid were the first to anticipate that probiotics and prebiotics could be combined as synbiotics back in 1995. Mary Ellen Sanders and Andreu Prados introduce our new selection of human research on the health benefits of synbiotics.